Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High cytogenetic or molecular genetic risk acute myeloid leukemia.

Hematology. American Society of Hematology. Education Program - 1 Jan 2010

Estey Elihu

Abstract excerpt

Resistance, manifested as failure to enter remission despite living long enough to do so or as relapse from remission, is the principal cause of therapeutic failure in acute myeloid leukemia, even in patients age ≥ 75. Recently, a "monosomal karyotype" in acute myeloid leukemia blasts has been found to be a principal predictor of resistance. It is also clear that patients with a normal karyotype, and other...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cytogenetic Analysis
Share to Gene Duplication

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to NPM1 gene

Share to Genetic Predisposition to Disease

Share to Leukemia, Myeloid, Acute

Share to Nucleophosmin

Share to Risk Factors

Source

Identifiers

PMID: 21239839
DOI: 10.1182/asheducation-2010.1.474

Genes

FLT3
NPM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High cytogenetic or molecular genetic risk acute myeloid leukemia.PMID 21239839Read ↗

Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

Is it important to decipher the heterogeneity of "normal karyotype AML"?Semantic proximity Read ↗

Molecular Genetic Markers in Acute Myeloid LeukemiaSemantic proximity Read ↗

When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matterSemantic proximity Read ↗

When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matterSemantic proximity Read ↗

Acute myeloid leukemia: the challenge of capturing disease variety.Semantic proximity Read ↗

Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrumSemantic proximity Read ↗

Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogeneticsSemantic proximity Read ↗

Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics.Semantic proximity Read ↗

Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.Semantic proximity Read ↗

Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International CohortsSemantic proximity Read ↗

Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.